We believe in helping people who are struggling with serious and debilitating diseases.
Learn More About UsSCIENCE
Delivering On
Unmet Needs
Unmet Needs
Every day we tackle tough challenges in science and medicine. Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses.
AMYOTROPHIC LATERAL SCLEROSIS
Our Relentless Commitment
Many people living with amyotrophic lateral sclerosis (ALS) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs.
Aug 29, 2023
Mitsubishi Tanabe Pharma America Presents Positive Results from Pivotal Phase 3 BouNDless Trial of Investigational ND0612 in People with Parkinson's Disease Experiencing Motor Fluctuations
Read More
Aug 28, 2023
Mitsubishi Tanabe Pharma America Announces Presentations in Parkinson’s Disease at 2023 International Congress of Parkinson's Disease and Movement Disorders Society (MDS)
Read More
Aug 17, 2023
Mitsubishi Tanabe Pharma America Announces Post-Hoc Analysis Examining Effect of Early Intervention with RADICAVA® (edaravone) on Survival and Disease Progression Milestones in People with ALS
Read More
Jul 31, 2023
Mitsubishi Tanabe Pharma America Announces Update on Global, Phase 3b MT-1186-A02 Postmarketing Study of Oral Edaravone in ALS
Read More
You are leaving this website, hosted by Mitsubishi Tanabe Pharma America, Inc.
This link will take you to a website to which our Privacy Policy and Terms of Use does
not apply. Mitsubishi Tanabe Pharma America, Inc. does not control the content of this third-party site.